We welcome Alizyme as a new client. Alizyme is a speciality biopharmaceutical development company, based in Cambridge, UK. They are focused on developing products for the treatment and management of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and motility, such as irritable bowel syndrome, of obesity and related diseases, such as diabetes, and of the gastrointestinal side effects of cancer therapy, such as mucositis.